Bryn Mawr Trust CO Uni Qure N.V. Transaction History
Bryn Mawr Trust CO
- $5.51 Billion
- Q2 2025
A detailed history of Bryn Mawr Trust CO transactions in Uni Qure N.V. stock. As of the latest transaction made, Bryn Mawr Trust CO holds 352 shares of QURE stock, worth $4,674. This represents 0.0% of its overall portfolio holdings.
Number of Shares
352
Previous 352
-0.0%
Holding current value
$4,674
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding QURE
# of Institutions
175Shares Held
50.6MCall Options Held
2.12MPut Options Held
455K-
Vestal Point Capital, LP New York, NY4.79MShares$63.6 Million3.63% of portfolio
-
Rtw Investments, LP New York, NY4.27MShares$56.6 Million0.74% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.99MShares$53 Million3.32% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.76MShares$36.6 Million1.32% of portfolio
-
Abrdn PLC2.75MShares$36.5 Million0.07% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $621M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...